Serveur d'exploration sur la grippe au Canada

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012).

Identifieur interne : 000414 ( Main/Exploration ); précédent : 000413; suivant : 000415

Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012).

Auteurs : Sumana Fathima [Canada] ; Bonita E. Lee ; Jennifer May-Hadford ; Shamir Mukhi ; Steven J. Drews

Source :

RBID : pubmed:23202503

Descripteurs français

English descriptors

Abstract

We investigated the proportions of mono vs. mixed infections for human metapneumovirus (hMPV) as compared to adenovirus (ADV), four types of coronavirus (CRV), parainfluenza virus (PIV), RSV, and enterovirus/rhinovirus (ERV) in Alberta, Canada. Using the Data Integration for Alberta Laboratories (DIAL) platform, 26,226 respiratory specimens at ProvLab between 1 July 2009 and 30 June 2012 were selected and included in the study. Using the Respiratory Virus Panel these specimens tested positive for one or more respiratory virus and negative for influenza A and B. From our subset hMPV was the fourth most common virus (n=2,561) with 373 (15%) identified as mixed infection using DIAL. Mixed infection with hMPV was most commonly found in infants less than 6 months old and ERV was most commonly found in mixed infection with hMPV (230/373, 56%) across all age groups. The proportion of mixed-infection vs. mono-infection was highest for ADV (46%), followed by CRV 229E (32%), CRV HKU1 (31%), CRV NL63 (28%), CRV OC43 (23%), PIV (20%), RSV (17%), hMPV (15%) and ERV (13%). hMPV was significantly more likely to be identified in mono infection as compared with ADV, CRV, PIV, and RSV with the exception of ERV [p < 0.05].

DOI: 10.3390/v4112754
PubMed: 23202503
PubMed Central: PMC3509671


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012).</title>
<author>
<name sortKey="Fathima, Sumana" sort="Fathima, Sumana" uniqKey="Fathima S" first="Sumana" last="Fathima">Sumana Fathima</name>
<affiliation wicri:level="1">
<nlm:affiliation>Provincial Laboratory for Public Health (ProvLab), 3030 Hospital Dr. NW, Calgary, Alberta, T2N 4W4, Canada. sumana.fathima@albertahealthservices.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Provincial Laboratory for Public Health (ProvLab), 3030 Hospital Dr. NW, Calgary, Alberta, T2N 4W4</wicri:regionArea>
<wicri:noRegion>T2N 4W4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lee, Bonita E" sort="Lee, Bonita E" uniqKey="Lee B" first="Bonita E" last="Lee">Bonita E. Lee</name>
</author>
<author>
<name sortKey="May Hadford, Jennifer" sort="May Hadford, Jennifer" uniqKey="May Hadford J" first="Jennifer" last="May-Hadford">Jennifer May-Hadford</name>
</author>
<author>
<name sortKey="Mukhi, Shamir" sort="Mukhi, Shamir" uniqKey="Mukhi S" first="Shamir" last="Mukhi">Shamir Mukhi</name>
</author>
<author>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:23202503</idno>
<idno type="pmid">23202503</idno>
<idno type="doi">10.3390/v4112754</idno>
<idno type="pmc">PMC3509671</idno>
<idno type="wicri:Area/Main/Corpus">000401</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000401</idno>
<idno type="wicri:Area/Main/Curation">000401</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000401</idno>
<idno type="wicri:Area/Main/Exploration">000401</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012).</title>
<author>
<name sortKey="Fathima, Sumana" sort="Fathima, Sumana" uniqKey="Fathima S" first="Sumana" last="Fathima">Sumana Fathima</name>
<affiliation wicri:level="1">
<nlm:affiliation>Provincial Laboratory for Public Health (ProvLab), 3030 Hospital Dr. NW, Calgary, Alberta, T2N 4W4, Canada. sumana.fathima@albertahealthservices.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Provincial Laboratory for Public Health (ProvLab), 3030 Hospital Dr. NW, Calgary, Alberta, T2N 4W4</wicri:regionArea>
<wicri:noRegion>T2N 4W4</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lee, Bonita E" sort="Lee, Bonita E" uniqKey="Lee B" first="Bonita E" last="Lee">Bonita E. Lee</name>
</author>
<author>
<name sortKey="May Hadford, Jennifer" sort="May Hadford, Jennifer" uniqKey="May Hadford J" first="Jennifer" last="May-Hadford">Jennifer May-Hadford</name>
</author>
<author>
<name sortKey="Mukhi, Shamir" sort="Mukhi, Shamir" uniqKey="Mukhi S" first="Shamir" last="Mukhi">Shamir Mukhi</name>
</author>
<author>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
</author>
</analytic>
<series>
<title level="j">Viruses</title>
<idno type="eISSN">1999-4915</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alberta (epidemiology)</term>
<term>Child, Preschool (MeSH)</term>
<term>Coinfection (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Infant, Newborn (MeSH)</term>
<term>Internet (MeSH)</term>
<term>Metapneumovirus (genetics)</term>
<term>Paramyxoviridae Infections (epidemiology)</term>
<term>Paramyxoviridae Infections (virology)</term>
<term>Public Health Surveillance (methods)</term>
<term>Respiratory Tract Infections (epidemiology)</term>
<term>Respiratory Tract Infections (virology)</term>
<term>Seasons (MeSH)</term>
<term>Viruses (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Alberta (épidémiologie)</term>
<term>Co-infection (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections de l'appareil respiratoire (virologie)</term>
<term>Infections de l'appareil respiratoire (épidémiologie)</term>
<term>Infections à Paramyxoviridae (virologie)</term>
<term>Infections à Paramyxoviridae (épidémiologie)</term>
<term>Internet (MeSH)</term>
<term>Metapneumovirus (génétique)</term>
<term>Nourrisson (MeSH)</term>
<term>Nouveau-né (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Surveillance de la santé publique (méthodes)</term>
<term>Virus (génétique)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Alberta</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Paramyxoviridae Infections</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Metapneumovirus</term>
<term>Viruses</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Metapneumovirus</term>
<term>Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Public Health Surveillance</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Surveillance de la santé publique</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
<term>Infections à Paramyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Paramyxoviridae Infections</term>
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Alberta</term>
<term>Infections de l'appareil respiratoire</term>
<term>Infections à Paramyxoviridae</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Child, Preschool</term>
<term>Coinfection</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Internet</term>
<term>Seasons</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Co-infection</term>
<term>Enfant d'âge préscolaire</term>
<term>Humains</term>
<term>Internet</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Saisons</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We investigated the proportions of mono vs. mixed infections for human metapneumovirus (hMPV) as compared to adenovirus (ADV), four types of coronavirus (CRV), parainfluenza virus (PIV), RSV, and enterovirus/rhinovirus (ERV) in Alberta, Canada. Using the Data Integration for Alberta Laboratories (DIAL) platform, 26,226 respiratory specimens at ProvLab between 1 July 2009 and 30 June 2012 were selected and included in the study. Using the Respiratory Virus Panel these specimens tested positive for one or more respiratory virus and negative for influenza A and B. From our subset hMPV was the fourth most common virus (n=2,561) with 373 (15%) identified as mixed infection using DIAL. Mixed infection with hMPV was most commonly found in infants less than 6 months old and ERV was most commonly found in mixed infection with hMPV (230/373, 56%) across all age groups. The proportion of mixed-infection vs. mono-infection was highest for ADV (46%), followed by CRV 229E (32%), CRV HKU1 (31%), CRV NL63 (28%), CRV OC43 (23%), PIV (20%), RSV (17%), hMPV (15%) and ERV (13%). hMPV was significantly more likely to be identified in mono infection as compared with ADV, CRV, PIV, and RSV with the exception of ERV [p < 0.05].</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">23202503</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>05</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1999-4915</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>4</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2012</Year>
<Month>Nov</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>Viruses</Title>
<ISOAbbreviation>Viruses</ISOAbbreviation>
</Journal>
<ArticleTitle>Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012).</ArticleTitle>
<Pagination>
<MedlinePgn>2754-65</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/v4112754</ELocationID>
<Abstract>
<AbstractText>We investigated the proportions of mono vs. mixed infections for human metapneumovirus (hMPV) as compared to adenovirus (ADV), four types of coronavirus (CRV), parainfluenza virus (PIV), RSV, and enterovirus/rhinovirus (ERV) in Alberta, Canada. Using the Data Integration for Alberta Laboratories (DIAL) platform, 26,226 respiratory specimens at ProvLab between 1 July 2009 and 30 June 2012 were selected and included in the study. Using the Respiratory Virus Panel these specimens tested positive for one or more respiratory virus and negative for influenza A and B. From our subset hMPV was the fourth most common virus (n=2,561) with 373 (15%) identified as mixed infection using DIAL. Mixed infection with hMPV was most commonly found in infants less than 6 months old and ERV was most commonly found in mixed infection with hMPV (230/373, 56%) across all age groups. The proportion of mixed-infection vs. mono-infection was highest for ADV (46%), followed by CRV 229E (32%), CRV HKU1 (31%), CRV NL63 (28%), CRV OC43 (23%), PIV (20%), RSV (17%), hMPV (15%) and ERV (13%). hMPV was significantly more likely to be identified in mono infection as compared with ADV, CRV, PIV, and RSV with the exception of ERV [p < 0.05].</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fathima</LastName>
<ForeName>Sumana</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Provincial Laboratory for Public Health (ProvLab), 3030 Hospital Dr. NW, Calgary, Alberta, T2N 4W4, Canada. sumana.fathima@albertahealthservices.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Bonita E</ForeName>
<Initials>BE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>May-Hadford</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mukhi</LastName>
<ForeName>Shamir</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Drews</LastName>
<ForeName>Steven J</ForeName>
<Initials>SJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>11</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Viruses</MedlineTA>
<NlmUniqueID>101509722</NlmUniqueID>
<ISSNLinking>1999-4915</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000416" MajorTopicYN="N" Type="Geographic">Alberta</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D029121" MajorTopicYN="Y">Metapneumovirus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018184" MajorTopicYN="N">Paramyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D062486" MajorTopicYN="N">Public Health Surveillance</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>08</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2012</Year>
<Month>10</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>10</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>5</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23202503</ArticleId>
<ArticleId IdType="pii">v4112754</ArticleId>
<ArticleId IdType="doi">10.3390/v4112754</ArticleId>
<ArticleId IdType="pmc">PMC3509671</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Influenza Other Respir Viruses. 2012 Jan;6(1):71-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21668660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(1):e16314</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21298115</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2001 Jun;7(6):719-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11385510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol Immunol Infect. 2011 Jun;44(3):184-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21524612</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2003 Mar 1;187(5):785-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12599052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2004 Apr 1;38(7):983-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15034830</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2007 Mar;38(3):221-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17241812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2006 Apr;25(4):320-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16567983</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2012 Sep 1;206(5):628-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22723641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2006 Apr;35(4):394-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16460998</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2012 Jul;84(7):1071-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22585724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2011 Oct;63(4):260-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21546090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2007 Sep 1;196(5):705-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17674312</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Apr;78(8):4363-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15047850</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2002 Nov 1;186(9):1330-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12402203</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2003 Oct;41(10):4642-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14532196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Feb;81(4):1786-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17151097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2005 May;76(1):98-105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15778961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2007 May 1;44(9):1152-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17407031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2003 Jun;9(6):634-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781001</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2010 Aug;48(4):239-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20646956</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2007 Mar;79(3):308-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17245714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zhonghua Er Ke Za Zhi. 2011 Oct;49(10):745-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22321179</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2007 Nov;40(3):186-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17870660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2008 Sep;46(9):3056-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18632902</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2010 Feb;29(2):131-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20135829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Online J Public Health Inform. 2010;2(3):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23569594</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2005 Aug;33(4):299-305</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16036180</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2004 Apr;10(4):700-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15200863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2011;8:277</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21645365</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Pharmacol. 2007 Oct;7(5):478-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17689145</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Drews, Steven J" sort="Drews, Steven J" uniqKey="Drews S" first="Steven J" last="Drews">Steven J. Drews</name>
<name sortKey="Lee, Bonita E" sort="Lee, Bonita E" uniqKey="Lee B" first="Bonita E" last="Lee">Bonita E. Lee</name>
<name sortKey="May Hadford, Jennifer" sort="May Hadford, Jennifer" uniqKey="May Hadford J" first="Jennifer" last="May-Hadford">Jennifer May-Hadford</name>
<name sortKey="Mukhi, Shamir" sort="Mukhi, Shamir" uniqKey="Mukhi S" first="Shamir" last="Mukhi">Shamir Mukhi</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Fathima, Sumana" sort="Fathima, Sumana" uniqKey="Fathima S" first="Sumana" last="Fathima">Sumana Fathima</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000414 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000414 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeCanadaV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23202503
   |texte=   Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009-2012).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23202503" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV4 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Sat Aug 8 18:52:12 2020. Site generation: Sat Feb 13 16:40:04 2021